Development of a machine learning model to predict overall survival results from randomized clinical trials of patients with metastatic prostate cancer.

被引：0
|
作者：
Sabbagh, Ali
Quigley, David Alan
Lillis, Nicholas
Zhang, Li
Friesner, Isabel D.
Bailey, Adina
Aggarwal, Rahul Raj
Chappidi, Meera Reddy
Singhal, Hari
Zhang, Ke
Greshock, Joel
Li, Jinhui
Yu, Margaret K.
Small, Eric J.
Hong, Julian C.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Radiol & Biomed Imaging, San Francisco, CA 94143 USA
[3] Janssen Res & Dev, San Francisco, CA USA
[4] Janssen Res & Dev La Jolla, San Diego, CA USA
[5] Johnson & Johnson Innovat Med, Res & Dev, Raritan, NJ USA
[6] Johnson & Johnson Med China, Shanghai, Peoples R China
[7] Janssen Res & Dev LLC, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5065
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data
    Guinney, Justin
    Wang, Tao
    Laajala, Teemu D.
    Winner, Kimberly Kanigel
    Bare, J. Christopher
    Neto, Elias Chaibub
    Khan, Suleiman A.
    Peddinti, Gopal
    Airola, Antti
    Pahikkala, Tapio
    Mirtti, Tuomas
    Yu, Thomas
    Bot, Brian M.
    Shen, Liji
    Abdallah, Kald
    Norman, Thea
    Friend, Stephen
    Stolovitzky, Gustavo
    Soule, Howard
    Sweeney, Christopher J.
    Ryan, Charles J.
    Scher, Howard I.
    Sartor, Oliver
    Xie, Yang
    Aittokallio, Tero
    Zhou, Fang Liz
    Costello, James C.
    Abdallah, Kald
    Aittokallio, Tero
    Airola, Antti
    Anghel, Catalina
    Azima, Helia
    Baertsch, Robert
    Ballester, Pedro J.
    Bare, Chris
    Bhandari, Vinayak
    Bot, Brian M.
    Dang, Cuong C.
    Dunba, Maria Bekker-Nielsen
    Buchardt, Ann-Sophie
    Buturovic, Ljubomir
    Cao, Da
    Chalise, Prabhakar
    Cho, Junwoo
    Chu, Tzu-Ming
    Coley, R. Yates
    Conjeti, Sailesh
    Correia, Sara
    Costello, James C.
    Dai, Ziwei
    LANCET ONCOLOGY, 2017, 18 (01): : 132 - 142
  • [42] Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials
    Ou, Fang-Shu
    Tang, Jun
    An, Ming-Wen
    Mandrekar, Sumithra J.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 23
  • [43] Charlson score to predict overall survival and cancer-related death in elderly patients featuring high-risk prostate cancer.
    Ordaz, Guzman
    Sanchez-Salas, Rafael
    Sivaraman, Arjun
    Joniau, Steven
    Bianchi, Marco Giorgio
    Briganti, Alberto
    Spahn, Martin
    Bastian, Patrick
    Chun, Jongi
    Chlosta, Piotr
    Gontero, Paolo
    Graefen, Marcus
    Karnes, R. Jeffrey
    Marchioro, Giansilvio
    Tombal, Bertrand F.
    Tosco, Lorenzo
    Van Der Poel, Henk
    Cathelineau, Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [44] Comment on: development and external validation of a model to predict overall survival in patients with resected gallbladder cancer
    Chakrabarti, Sakti
    Mahipal, Amit
    HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (01) : 136 - 138
  • [45] Interpretable machine learning model for prediction of overall survival in laryngeal cancer
    Alabi, Rasheed Omobolaji
    Almangush, Alhadi
    Elmusrati, Mohammed
    Leivo, Ilmo
    Makitie, Antti A.
    ACTA OTO-LARYNGOLOGICA, 2025, 145 (03) : 256 - 262
  • [46] Development and validation of a deep learning model to predict survival of patients with esophageal cancer
    Huang, Chen
    Dai, Yongmei
    Chen, Qianshun
    Chen, Hongchao
    Lin, Yuanfeng
    Wu, Jingyu
    Xu, Xunyu
    Chen, Xiao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer
    Zhu, Feng
    Zhong, Ran
    Li, Feng
    Li, Caichen
    Din, Noren
    Sweidan, Hisham
    Potluri, Lakshmi Bhavani
    Xiong, Shan
    Li, Jianfu
    Cheng, Bo
    Chen, Zhuxing
    He, Jianxing
    Liang, Wenhua
    Pan, Zhenkui
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 471 - +
  • [48] Intermediate end point for survival for patients with hormone refractory metastatic prostate cancer.
    D'Amico, AV
    Chen, MH
    Cox, MC
    Dahut, W
    Figg, WD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 391S - 391S
  • [49] Impact of advances in therapy on survival in patients with de novo metastatic prostate cancer.
    Adekolujo, Orimisan Samuel
    Akanbi, Maxwell Oluwole
    Wahab, Ahsan
    Mosalem, Osama
    Adekolujo, Oyebimpe O.
    Wang, Ling
    Hrinczenko, Borys
    Isaac, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17052 - E17052
  • [50] Challenges with overall survival as an endpoint for efficacy assessment in first line metastatic breast cancer randomized controlled clinical trials and the investigation of truncated overall survival as an alternative endpoint
    Neate C.
    Strasak A.
    Burger H.U.
    Tong B.
    Kaiser L.
    memo - Magazine of European Medical Oncology, 2014, 7 (3) : 162 - 168
12345